Boardroom Battle Erupts at Staar Surgical Ahead of Crucial Vote
Published on 12/04/2025 at 15:22 | Redaktion boerse-global.de
A dramatic power struggle is unfolding at ophthalmic device maker Staar Surgical, casting severe doubt over its pending acquisition by industry giant Alcon. The company’s largest shareholder, activist investor Broadwood Partners, has launched a direct assault on the leadership team by demanding a special meeting to oust three key directors.
Broadwood Partners, which controls a significant 30.2% stake in Staar Surgical, is seeking the immediate removal of Board Chair Elizabeth Yeu, Chief Executive Stephen Farrell, and Compensation Committee Chair Arthur Butcher. The investor has sharply criticized the company’s strategic direction, labeling the sales process as “flawed” and arguing that the proposed transaction with Alcon severely undervalues the business.
Concerns Read more...
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
